Intellia Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 02/04/2025 | 12.54 M | $146.17 M | 2.29% | 12.41% |
| BLACKROCK, INC. | 02/07/2025 | 10.86 M | $126.60 M | 11.10% | 10.75% |
| VANGUARD GROUP INC | 02/11/2025 | 10.19 M | $118.82 M | 5.84% | 10.09% |
| STATE STREET CORP | 02/14/2025 | 5.21 M | $60.70 M | 1.21% | 5.15% |
| MORGAN STANLEY | 02/14/2025 | 3.81 M | $44.48 M | 48.08% | 3.78% |
| REGENERON PHARMACEUTICALS, INC. | 02/07/2025 | 3.70 M | $43.18 M | 100.00% | 3.67% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 01/28/2025 | 2.99 M | $34.89 M | -4.98% | 2.96% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 02/10/2025 | 2.99 M | $34.89 M | -4.95% | 2.96% |
| CITADEL ADVISORS LLC | 02/14/2025 | 2.49 M | $29.08 M | 152.07% | 2.47% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.39 M | $27.86 M | 1.96% | 2.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 2.31 M | $26.89 M | 207.56% | 2.28% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 2.03 M | $23.73 M | 96.70% | 2.01% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 2.00 M | $23.32 M | 0.00% | 1.98% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 2.00 M | $23.30 M | 94.46% | 1.98% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.98 M | $23.04 M | 36.55% | 1.96% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 1.84 M | $21.50 M | 88.06% | 1.83% |
| UBS GROUP AG | 02/14/2025 | 1.74 M | $20.31 M | 525.56% | 1.72% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.53 M | $17.80 M | 226.81% | 1.51% |
| FMR LLC | 02/13/2025 | 1.25 M | $14.61 M | -46.45% | 1.24% |
| 02/11/2025 | 1.01 M | $11.80 M | 100.00% | 1.00% | |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 02/13/2025 | 985,715 | $11.49 M | -8.37% | 0.98% |
| NORTHERN TRUST CORP | 02/14/2025 | 979,137 | $11.42 M | 13.03% | 0.97% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 787,490 | $9.18 M | -4.84% | 0.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 699,814 | $8.16 M | 8.54% | 0.69% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 668,926 | $7.80 M | 190.46% | 0.66% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 667,632 | $7.78 M | 100.00% | 0.66% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 644,116 | $7.51 M | 100.00% | 0.64% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 639,696 | $7.46 M | -10.68% | 0.63% |
| DISCOVERY VALUE FUND | 02/12/2025 | 561,561 | $6.55 M | 0.00% | 0.56% |
| JPMORGAN CHASE & CO | 02/12/2025 | 558,518 | $6.51 M | -13.95% | 0.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 527,620 | $6.15 M | 26.51% | 0.52% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 525,000 | $6.12 M | 100.00% | 0.52% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 512,300 | $5.97 M | 52.93% | 0.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 492,100 | $5.74 M | 100.00% | 0.49% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 483,185 | $5.63 M | 5.04% | 0.48% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 481,567 | $5.62 M | 154.89% | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 466,080 | $5.43 M | 60.12% | 0.46% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 453,821 | $5.29 M | 3.51% | 0.45% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 438,458 | $5.11 M | 77.97% | 0.43% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 411,077 | $4.79 M | 100.00% | 0.41% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 397,761 | $4.64 M | 320.42% | 0.39% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 02/06/2025 | 375,291 | $5.41 M | 14.33% | 0.37% |
| JUMP FINANCIAL, LLC | 02/13/2025 | 362,637 | $4.23 M | 94.18% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 337,600 | $3.94 M | -14.12% | 0.33% |
| PDT PARTNERS, LLC | 02/14/2025 | 327,608 | $3.82 M | 2,111.48% | 0.32% |
| BARCLAYS PLC | 02/13/2025 | 311,632 | $3.63 M | 6.43% | 0.31% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 306,510 | $3.57 M | 8.10% | 0.30% |
| CITADEL ADVISORS LLC | 02/14/2025 | 295,800 | $3.45 M | 140.68% | 0.29% |
| CHEVY CHASE TRUST HOLDINGS, LLC | 01/30/2025 | 288,321 | $3.36 M | -64.45% | 0.29% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 284,614 | $3.32 M | -1.29% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Intellia Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 377 institutional investors and hedge funds held shares of Intellia Therapeutics, Inc.. The most heavily invested institutionals were:
Global Financial Private Client, LLC: 0
ARK Investment Management LLC: 12.54 M
BlackRock, Inc.: 10.86 M
VANGUARD GROUP INC: 10.19 M
STATE STREET CORP: 5.21 M
MORGAN STANLEY: 3.81 M
98.29% of Intellia Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 114.49 M shares in the last 24 months. This purchase volume represents approximately $848.41 M in transactions.